Skip to content

Comparison of two intervention pain modalities for cancer pain.

Randomised double-blind comparative clinical study to compare efficacy of thoracic splanchnic nerves radiofrequency ablation at T11 and alcohol chemical neurolysis in upper abdominal cancer pain. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059666
Enrollment
42
Registered
2023-11-08
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Radiofrequency ablation of splanchnic nerves: Radiofrequency ablation of splanchnic nerves at T11 level. Agent and sequence: 1)2mL of local anaesthetic each side.(2% Lignocaine + 0.25%

Sponsors

All India Institute of Medical Sciences, Raipur, Cggattisgarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cancer of Pancreas, gallbladder, Liver, Stomach, Intestine up to splenic flexure of colon, lower one third of oesophagus. (Upper GI Malignancy) 2. Cancer pain not responding to morphine and other opioids like buprenorphine, fentanyl patch 3. Coagulation parameters within normal limits 4. Life expectancy more than 3 months

Exclusion criteria

Exclusion criteria: 1. Uncontrolled international normalized ratio (INR) 2. Systemic or local infection 3. Expected survival less than 3 months, an 4. Eastern Cooperative Oncology Group (ECOG) score less than 3 5. Presence of a medical or psychiatric illness that would preclude informed consent or follow-up 6. Patient mentally retarded, not following verbal commands during radiofrequency ablation when checking sensory and motor testing

Design outcomes

Primary

MeasureTime frame
To compare the pain relief after bilateral thoracic splanchnic nerve radiofrequency ablation at T11 with chemical neurolysis with absolute alcohol at T11.Timepoint: to assess at 7,14,21,28 days

Secondary

MeasureTime frame
To compare the incidence of side effects such as diarrhoea, hypotension and reduction in oral morphine consumption, improvement in quality of life between two techniques.Timepoint: to assess at 7,14,21,28 days

Countries

India

Contacts

Public ContactDr Rampal Singh

All India Institute Of Medical Sciences, Raipur, Chhattisgarh

lautikasingh@gmail.com9457086753

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026